Aspen Pharmacare Holdings Limited
APNHYOTCHealthcare● Active
$9.03
+$0.16(+1.80%)
Market Cap$4.0B
P/E Ratio—
52W High$9.03
52W Low$5.24
Aspen Pharmacare Holdings Limited (APNHY) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · APNHY · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $43.36B | $44.71B | $40.71B | $38.61B | $37.77B |
| Cost of Revenue | $24.23B | $25.29B | $22.30B | $20.30B | $19.98B |
| Gross Profit | $19.13B | $19.42B | $18.41B | $18.31B | $17.79B |
| Gross Margin %(computed) | 44.11% | 43.43% | 45.22% | 47.42% | 47.10% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.16B | $0.21B | $0.43B | $0.26B |
| G&A Expenses | $3.95B | $3.63B | $1.68B | $1.48B | $1.84B |
| Total Operating Expenses | $17.69B | $12.42B | $11.05B | $9.63B | $10.72B |
| Operating Income | $1.44B | $7.00B | $7.82B | $8.67B | $7.07B |
| Operating Margin %(computed) | 3.31% | 15.65% | 19.21% | 22.46% | 18.73% |
| Interest Income | $0.36B | $1.00B | $0.51B | $0.09B | $0.11B |
| Interest Expense | $1.65B | $2.23B | $1.32B | $0.77B | $1.21B |
| Income Before Tax | ($0.12B) | $5.71B | $6.55B | $8.13B | $5.99B |
| Income Tax Expense | $0.96B | $1.31B | $1.33B | $1.65B | $1.19B |
| Net Income | ($1.08B) | $4.40B | $5.23B | $6.49B | $4.81B |
| Net Margin %(computed) | -2.50% | 9.85% | 12.84% | 16.81% | 12.73% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.44 | $9.91 | $11.77 | $14.32 | $10.53 |
| Wtd Avg Shares | 0.44B | 0.44B | 0.44B | 0.45B | 0.46B |
| EBITDA | $2.16B | $9.90B | $10.19B | $9.93B | $8.67B |
| EBITDA Margin %(computed) | 4.98% | 22.16% | 25.03% | 25.73% | 22.95% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · ZAR · B
Explore more Aspen Pharmacare Holdings Limited data
About Aspen Pharmacare Holdings Limited (APNHY) Income Statement
Aspen Pharmacare Holdings Limited (APNHY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, APNHY reported revenue of $43.36B, gross profit of $19.13B (gross margin 44.11%), and net income of ($1.08B) — a net profit margin of -2.50%.
Frequently asked questions
APNHY · 4 questionsAspen Pharmacare Holdings Limited (APNHY) reported revenue of $43.36B for 2025, down 3.0% year-over-year.
APNHY revenueAPNHY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08